HIV drug resistance strategy, 2021 update

HIV drug resistance strategy, 2021 update

This publication provides an overview of the core set of WHO-recommended activities at the country level, with the aim of supporting programme planning and budgeting. The core activities on HIV drug resistancerecommended by WHO are:
developing and implementing the national action plan on HIV drug resistance;
monitoring the quality-of-care indicators associated with and predicting HIV drug resistance (also known as early warning indicators of HIV drug resistance); and implementing HIV drug resistance surveys

This publication also briefly summarizes the purpose and structure of the HIV Drug Resistance LaboratoryNetwork, the WHO HIV drug resistance database and the recommendation on timely dissemination and use of HIV drug resistance survey data at the country level.